FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2886203450> ?p ?o ?g. }

• W2886203450 endingPage "2387" @default.
• W2886203450 startingPage "2381" @default.
• W2886203450 abstract "Comparison of biosimilar filgrastim with a reference product: pharmacokinetics, pharmacodynamics, and safety profiles in healthy volunteers Chungam Choi,1 Byung Won Yoo,2 Choon Ok Kim,2 Taegon Hong,2 Byung Hak Jin,2 Kwang-Seok Seo,3 Ja Yun Jang,4 Min Soo Park2 1Department of Nuclear Medicine, Severance Hospital, Yonsei University Health System, Seoul, Republic of Korea; 2Department of Clinical Pharmacology, Severance Hospital, Yonsei University Health System, Seoul, Republic of Korea; 3Biopharmaceutical Research Laboratories, Dong-A Socio R&D Center, Yongin-si, Republic of Korea; 4Product Development Division, Dong-A ST Co., Ltd, Seoul, Republic of Korea Purpose: Filgrastim, a granulocyte-colony stimulating factor, is used to treat patients with neutropenia, including neutropenic fever. Leucostim® is a recombinant filgrastim product tested for biosimilarity with its reference product, Neupogen®. We conducted a comparative clinical trial of the 2 products. Patients and methods: A randomized, open-label, 2-way crossover, single-dose Phase I study was conducted for 56 healthy subjects. After a 5 and 10 μg/kg single subcutaneous administration of test and reference product, pharmacokinetic and pharmacodynamic parameters (absolute neutrophil count and CD34+ cell count) were compared. During the study, safety tests and adverse event monitoring were performed. Results: The test and the reference products had a comparable pharmacokinetic, pharmacodynamic, and safety profile. In both 5 and 10 μg/kg dosing, the 90% CIs of the test to reference ratio for primary parameters (peak plasma concentration and area under the plasma concentration vs time curve from time 0 extrapolated to the infinite time for plasma filgrastim concentration; maximal effect and area under the time-effect curve from time 0 to time of the last quantifiable effect for absolute neutrophil count) were within the 0.8–1.25 range. In addition, safety profiles between the 2 products were similar without any serious adverse events. Conclusion: This study has provided firm clinical evidence that the test filgrastim product is similar to its reference filgrastim product. Keywords: bioequivalence, biosimilar, G-CSF, biologics" @default.
• W2886203450 created "2018-08-22" @default.
• W2886203450 creator A5011820335 @default.
• W2886203450 creator A5048028604 @default.
• W2886203450 creator A5052341705 @default.
• W2886203450 creator A5073405708 @default.
• W2886203450 creator A5075482380 @default.
• W2886203450 creator A5076740216 @default.
• W2886203450 creator A5081251838 @default.
• W2886203450 creator A5085332322 @default.
• W2886203450 date "2018-08-01" @default.
• W2886203450 modified "2023-10-16" @default.
• W2886203450 title "Comparison of biosimilar filgrastim with a reference product: pharmacokinetics, pharmacodynamics, and safety profiles in healthy volunteers" @default.
• W2886203450 cites W1546909751 @default.
• W2886203450 cites W1889262944 @default.
• W2886203450 cites W1968659034 @default.
• W2886203450 cites W1993608325 @default.
• W2886203450 cites W1998530305 @default.
• W2886203450 cites W2020476117 @default.
• W2886203450 cites W2024933507 @default.
• W2886203450 cites W2029054762 @default.
• W2886203450 cites W2032922280 @default.
• W2886203450 cites W2036684015 @default.
• W2886203450 cites W2042418092 @default.
• W2886203450 cites W2122038099 @default.
• W2886203450 cites W2123859227 @default.
• W2886203450 cites W2341557816 @default.
• W2886203450 cites W47829030 @default.
• W2886203450 doi "https://doi.org/10.2147/dddt.s158277" @default.
• W2886203450 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6078186" @default.
• W2886203450 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30122896" @default.
• W2886203450 hasPublicationYear "2018" @default.
• W2886203450 type Work @default.
• W2886203450 sameAs 2886203450 @default.
• W2886203450 citedByCount "2" @default.
• W2886203450 countsByYear W28862034502020 @default.
• W2886203450 countsByYear W28862034502021 @default.
• W2886203450 crossrefType "journal-article" @default.
• W2886203450 hasAuthorship W2886203450A5011820335 @default.
• W2886203450 hasAuthorship W2886203450A5048028604 @default.
• W2886203450 hasAuthorship W2886203450A5052341705 @default.
• W2886203450 hasAuthorship W2886203450A5073405708 @default.
• W2886203450 hasAuthorship W2886203450A5075482380 @default.
• W2886203450 hasAuthorship W2886203450A5076740216 @default.
• W2886203450 hasAuthorship W2886203450A5081251838 @default.
• W2886203450 hasAuthorship W2886203450A5085332322 @default.
• W2886203450 hasBestOaLocation W28862034501 @default.
• W2886203450 hasConcept C111113717 @default.
• W2886203450 hasConcept C112705442 @default.
• W2886203450 hasConcept C126322002 @default.
• W2886203450 hasConcept C197934379 @default.
• W2886203450 hasConcept C22979827 @default.
• W2886203450 hasConcept C2776694085 @default.
• W2886203450 hasConcept C2777063308 @default.
• W2886203450 hasConcept C2777288759 @default.
• W2886203450 hasConcept C2777767877 @default.
• W2886203450 hasConcept C2779171977 @default.
• W2886203450 hasConcept C29730261 @default.
• W2886203450 hasConcept C59491497 @default.
• W2886203450 hasConcept C71924100 @default.
• W2886203450 hasConcept C74133956 @default.
• W2886203450 hasConcept C76318530 @default.
• W2886203450 hasConcept C98274493 @default.
• W2886203450 hasConceptScore W2886203450C111113717 @default.
• W2886203450 hasConceptScore W2886203450C112705442 @default.
• W2886203450 hasConceptScore W2886203450C126322002 @default.
• W2886203450 hasConceptScore W2886203450C197934379 @default.
• W2886203450 hasConceptScore W2886203450C22979827 @default.
• W2886203450 hasConceptScore W2886203450C2776694085 @default.
• W2886203450 hasConceptScore W2886203450C2777063308 @default.
• W2886203450 hasConceptScore W2886203450C2777288759 @default.
• W2886203450 hasConceptScore W2886203450C2777767877 @default.
• W2886203450 hasConceptScore W2886203450C2779171977 @default.
• W2886203450 hasConceptScore W2886203450C29730261 @default.
• W2886203450 hasConceptScore W2886203450C59491497 @default.
• W2886203450 hasConceptScore W2886203450C71924100 @default.
• W2886203450 hasConceptScore W2886203450C74133956 @default.
• W2886203450 hasConceptScore W2886203450C76318530 @default.
• W2886203450 hasConceptScore W2886203450C98274493 @default.
• W2886203450 hasLocation W28862034501 @default.
• W2886203450 hasLocation W28862034502 @default.
• W2886203450 hasLocation W28862034503 @default.
• W2886203450 hasLocation W28862034504 @default.
• W2886203450 hasLocation W28862034505 @default.
• W2886203450 hasOpenAccess W2886203450 @default.
• W2886203450 hasPrimaryLocation W28862034501 @default.
• W2886203450 hasRelatedWork W1889262944 @default.
• W2886203450 hasRelatedWork W1899458195 @default.
• W2886203450 hasRelatedWork W2050383104 @default.
• W2886203450 hasRelatedWork W2136859014 @default.
• W2886203450 hasRelatedWork W2141193653 @default.
• W2886203450 hasRelatedWork W2350798671 @default.
• W2886203450 hasRelatedWork W2886203450 @default.
• W2886203450 hasRelatedWork W2899146514 @default.
• W2886203450 hasRelatedWork W3080627480 @default.
• W2886203450 hasRelatedWork W3204611093 @default.
• W2886203450 hasVolume "Volume 12" @default.
• W2886203450 isParatext "false" @default.

• next